<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id><journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id><journal-title-group><journal-title>BMC Research Notes</journal-title></journal-title-group><issn pub-type="epub">1756-0500</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25885799</article-id><article-id pub-id-type="pmc">4383206</article-id><article-id pub-id-type="publisher-id">1066</article-id><article-id pub-id-type="doi">10.1186/s13104-015-1066-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Pilot study on the effects of a 2-week hiking vacation at moderate versus low altitude on plasma parameters of carbohydrate and lipid metabolism in patients with metabolic syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gutwenger</surname><given-names>Ivana</given-names></name><address><email>ivana.gtw@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Hofer</surname><given-names>Georg</given-names></name><address><email>hofer.geo@rolmail.net</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Gutwenger</surname><given-names>Anna K</given-names></name><address><email>gutwenger.anja@rolmail.net</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Sandri</surname><given-names>Marco</given-names></name><address><email>info@msandri.it</email></address><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wiedermann</surname><given-names>Christian J</given-names></name><address><email>christian.wiedermann@asbz.it</email></address><xref ref-type="aff" rid="Aff5"/><xref ref-type="aff" rid="Aff6"/></contrib><aff id="Aff1"><label/>Department of Anesthesiology, Hospital of Bressanone | Brixen, Bressanone | Brixen (BZ), Italy </aff><aff id="Aff2"><label/>Department of Anesthesiology, Hospital of Silandro, Schlanders (BZ), Italy </aff><aff id="Aff3"><label/>Department of Internal Medicine, Hospital of Silandro | Schlanders, Silandro | Schlanders (BZ), Italy </aff><aff id="Aff4"><label/>Data, Methods and Systems Statistical Laboratory, University of Brescia, Brescia (BS), Italy </aff><aff id="Aff5"><label/>Department of Internal Medicine, Central Hospital of Bolzano | Bozen, Bolzano | Bozen (BZ), Italy </aff><aff id="Aff6"><label/>Interdisciplinary Medical Research Center South Tyrol (IMREST), Bolzano | Bozen (BZ), Italy </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>8</volume><elocation-id>103</elocation-id><history><date date-type="received"><day>7</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>18</day><month>3</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Gutwenger et al.; licensee BioMed Central. 2015</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Hypoxic and hypobaric conditions may augment the beneficial influence of training on cardiovascular risk factors. This pilot study aimed to explore for effects of a two-week hiking vacation at moderate versus low altitude on adipokines and parameters of carbohydrate and lipid metabolism in patients with metabolic syndrome.</p></sec><sec><title>Methods</title><p>Fourteen subjects (mean age: 55.8&#x000a0;years, range: 39 &#x02013; 69) with metabolic syndrome participated in a 2-week structured training program (3&#x000a0;hours of guided daily hiking 4 times a week, training intensity at 55-65% of individual maximal heart rate; total training time, 24&#x000a0;hours). Participants were divided for residence and training into two groups, one at moderate altitude (1,900&#x000a0;m; n&#x02009;=&#x02009;8), and the other at low altitude (300&#x000a0;m; n&#x02009;=&#x02009;6). Anthropometric, cardiovascular and metabolic parameters were measured before and after the training period.</p></sec><sec><title>Results</title><p>In study participants, training overall reduced circulating levels of total cholesterol (p&#x02009;=&#x02009;0.024), low-density lipoprotein cholesterol (p&#x02009;=&#x02009;0.025) and adiponectin (p&#x02009;&#x0003c;&#x02009;0.001). In the group training at moderate altitude (n&#x02009;=&#x02009;8), lowering effects on circulating levels were significant not only for total cholesterol, low-density-lipoprotein cholesterol and adiponectin (all, p&#x02009;&#x0003c;&#x02009;0.05) but also for triglycerides (p&#x02009;=&#x02009;0.025) and leptin (p&#x02009;=&#x02009;0.015), whereas in the low altitude group (n&#x02009;=&#x02009;6), none of the lipid parameters was significantly changed (each p&#x02009;&#x0003e;&#x02009;0.05). Hiking-induced relative changes of triglyceride levels were positively associated with reductions in leptin levels (p&#x02009;=&#x02009;0.006). As compared to 300&#x000a0;m altitude, training at 1,900&#x000a0;m showed borderline significant differences in the pre-post mean reduction rates of triglyceride (p&#x02009;=&#x02009;0.050) and leptin levels (p&#x02009;=&#x02009;0.093).</p></sec><sec><title>Conclusions</title><p>Preliminary data on patients with metabolic syndrome suggest that a 2-week hiking vacation at moderate altitude may be more beneficial for adipokines and parameters of lipid metabolism than training at low altitude. In order to draw firm conclusions regarding better corrections of dyslipidemia and metabolic syndrome by physical exercise under mild hypobaric and hypoxic conditions, a sufficiently powered randomized clinical trial appears warranted.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.gov ID <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02013947">NCT02013947</ext-link> (first received November 6, 2013).</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Exercise</kwd><kwd>Moderate altitude</kwd><kwd>Hypoxia</kwd><kwd>Metabolic syndrome</kwd><kwd>Triglyceride</kwd><kwd>Cholesterol</kwd><kwd>Adipokine</kwd><kwd>Leptin</kwd><kwd>Adiponectin</kwd><kwd>Vacation</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Risk factors for cardiovascular disease and diabetes mellitus include abdominal adiposity, insulin resistance, impaired glucose tolerance, and arterial hypertension, which are often associated with elevations in fasting triglycerides (TG) and glucose in addition to elevated low-density-lipoprotein cholesterol (LDL-C) and decreased high-density lipoprotein cholesterol (HDL-C) levels [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>]. This clustering of risk factors is termed the &#x0201c;metabolic syndrome&#x0201d; (MetS) [<xref ref-type="bibr" rid="CR3">3</xref>]. Increased visceral adipose tissue is integral to the development of MetS, which increases the risk not only of type 2 diabetes and cardiovascular disease complications but also of cancer, sleep disorders, sexual dysfunction, and mortality [<xref ref-type="bibr" rid="CR4">4</xref>-<xref ref-type="bibr" rid="CR7">7</xref>].</p><p>In individuals with increased adipose tissue, circulating levels of adiponectin, a protein released exclusively from adipocytes that has anti-diabetic and anti-atherosclerotic properties, are decreased [<xref ref-type="bibr" rid="CR8">8</xref>]. Furthermore, decreased adiponectin is associated with high TG [<xref ref-type="bibr" rid="CR9">9</xref>] and low HDL-C levels [<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref>], as also with hypertension [<xref ref-type="bibr" rid="CR12">12</xref>], suggesting that adiponectin is involved in the pathogenesis of MetS [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p>Leptin, another adipokine, is also a fat cell-derived mediator that acts centrally on the hypothalamus to reduce food intake and increase energy utilization. In obese persons, concentrations of leptin are high and correlate directly with the mass of white adipose tissue [<xref ref-type="bibr" rid="CR14">14</xref>]. Through inflammatory and pro-atherogenic properties, also leptin provides a functional link between obesity and cardiovascular disease [<xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref>].</p><p>Exercise training can have profound effects on reducing visceral adiposity and other cardiovascular risk factors associated with MetS [<xref ref-type="bibr" rid="CR17">17</xref>-<xref ref-type="bibr" rid="CR19">19</xref>]. Exercise exerts beneficial effects partly through alterations in the adipokine profile, and exercise-induced reductions of leptin may be of particular relevance [<xref ref-type="bibr" rid="CR20">20</xref>]. It is known that obese persons working at moderate to high altitude lose weight [<xref ref-type="bibr" rid="CR21">21</xref>-<xref ref-type="bibr" rid="CR23">23</xref>]. Altitude hypoxia has been identified as an important trigger of this beneficial effect and controlled hypoxia may well become a new therapeutic strategy to improve management of MetS [<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref>]. Exercising at moderate altitude may represent a superimposed intermittent hypoxia-like stimulus causing beneficial pre-conditioning effects [<xref ref-type="bibr" rid="CR26">26</xref>]. Hypoxia-inducible factor pathways are involved in beneficially regulating glucose and lipid metabolism, which might have impact on cardio- and cerebrovascular systems and be responsible for the reduction of cardiovascular mortality at altitude [<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref>]. For altitude to exert beneficial effects on lipid parameters, individuals probably do not need to be acclimatized first [<xref ref-type="bibr" rid="CR29">29</xref>]; however, changes of parameters of glucose metabolism may require prolonged exposure to intermittent hypoxia-like stimuli [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p>In the &#x0201c;Austrian Moderate Altitude Study [<xref ref-type="bibr" rid="CR31">31</xref>]&#x0201d;, patients with MetS tolerated a 3-week hiking vacation at 1,700&#x000a0;m without any physical problems and showed short-term favorable effects on blood pressure, fat and glucose metabolism [<xref ref-type="bibr" rid="CR31">31</xref>-<xref ref-type="bibr" rid="CR34">34</xref>]. To date, however, no study has examined the effect of a hiking vacation at moderate altitude on adipokine levels of patients with MetS [<xref ref-type="bibr" rid="CR35">35</xref>]. The present pilot study was, therefore, designed to explore the impact of a 2-week hypoxic living and exercise stay on lipid and glucose metabolism as related to circulating levels of adiponectin and leptin. It was hypothesized that moderate exercise under the hypobaric hypoxic conditions at 1,900 meters above sea level would affect lipid metabolism parameters and adipokine plasma levels of patients with MetS more effectively than moderate exercise at 300 meters above sea level.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods</title><sec id="Sec3"><title>Study participants</title><p>The study was performed on patients with MetS defined according to the 2009 International Diabetes Federation, National Heart, Lung and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity criteria by the presence of any three of the following five risk factors [<xref ref-type="bibr" rid="CR3">3</xref>]: waist circumference, men &#x0003e;102&#x000a0;cm, women &#x0003e;88&#x000a0;cm; fasting TG, &#x0003e;150&#x000a0;mg/dL or drug treatment for elevated TG; serum HDL-C, &#x0003c;40&#x000a0;mg/dL, women &#x0003c;50&#x000a0;mg/dL; arterial blood pressure, &#x0003e;130/85&#x000a0;mmHg or drug treatment for hypertension; fasting plasma glucose, &#x0003e;100&#x000a0;mg/dL or drug treatment for hyperglycemia. The study was approved by the Ethics Committee of the Autonomous Province of Bolzano/Bozen (Italy).</p><p>Subjects with MetS were recruited by general practitioners (GPs) between September and October 2013. Forty GPs from South Tyrol (Italy) and from the region of Regensburg (Bavaria, Germany) were invited to collaborate in the recruitment of study subjects. The final participation rate was 20% (8 of 40 GPs invited in writing) who identified 14 subjects with MetS interested and able to participate in the study. Inclusion and exclusion criteria had been checked and approved by the principal investigator who also obtained informed consent upon recruitment. Three to seven days before arrival at the study site, exercise testing on a bicycle ergometer up to maximum physical exhaustion was performed with a stepwise increase of workload at the normal living altitudes of the study subjects.</p></sec><sec id="Sec4"><title>Design and outcome</title><p>The present study is characterized by a pre-post design type (measurements at baseline T<sub>0</sub> and at the end of the training period T<sub>1</sub>) [<xref ref-type="bibr" rid="CR36">36</xref>] with two randomized groups. The aim was to compare, through biomarkers relevant for MetS, subjects&#x02019; response under two different experimental conditions: exercise program at 300&#x000a0;m versus 1,900&#x000a0;m above sea level.</p><p>The 14 participants were assigned to two groups: one group (n&#x02009;=&#x02009;8) stayed and exercised under mild hypoxic and hypobaric conditions at 1,900&#x000a0;m altitude for two weeks (Sulden/Solda, Autonomous Province of Bozen/Bolzano, Italy), and the other (n&#x02009;=&#x02009;6) at 300&#x000a0;m altitude (Nals/Nales, Autonomous Province of Bozen/Bolzano, Italy). Definition of MetS of study subjects is given in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Altitudes at which participants lived before the study were as follows (mean&#x02009;&#x000b1;&#x02009;SD): low altitude group: 749.2&#x02009;&#x000b1;&#x02009;157.6&#x000a0;m (range 559&#x02013;956); moderate altitude group, 785.5&#x02009;&#x000b1;&#x02009;154.4 (range 528&#x02013;921). There was no adaptation period for individuals at their study altitudes before the start of the exercise intervention. Both groups participated in the supervised training program of hiking three hours a day, four times a week (total training time, 24&#x000a0;hours) at an intensity of 55&#x02013;65% of the individual maximal heart rate. Heart rate was continuously monitored during the exercise with heart rate monitors Polar FT1 (Polar Electro, Bologna, Italy). Each subject was personally supervised by the exercise therapists during all training sessions in order to be sure that heart rates were maintained within the individually defined target range. During the 2-week intervention period, no specific diet plan was followed, and participants were asked to take their medications as usual. The breakfast was offered as a typical buffet breakfast at the hotel. Lunch and dinner consisted of a starter or soup, main course and dessert each. Drinks were not controlled and included alcoholic beverages.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Definition of MetS in study participants</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Patient no. and code</bold>
</th><th>
<bold>Sex (m/f)</bold>
</th><th>
<bold>Age (yrs)</bold>
</th><th>
<bold>Waist circumference (cm)</bold>
</th><th>
<bold>Fasting TG &#x0003e;150&#x000a0;mg/dL or drug treatment for elevated TG (yes/no)</bold>
</th><th>
<bold>Serum HDL-C (mg/dl)</bold>
</th><th>
<bold>Arterial blood pressure &#x0003e;130/85&#x000a0;mmHg or drug treatment for hypertension (yes/no)</bold>
</th><th>
<bold>Fasting plasma glucose &#x0003e;100&#x000a0;mg/dL or drug treatment for hyperglycemia (yes/no)</bold>
</th></tr></thead><tbody><tr valign="top"><td colspan="8">Moderate altitude</td></tr><tr valign="top"><td>1/003</td><td>M</td><td align="left">54</td><td align="left">125</td><td>Yes</td><td align="left">38</td><td>Yes</td><td>Yes</td></tr><tr valign="top"><td>2/006</td><td>M</td><td align="left">39</td><td align="left">122</td><td>Yes</td><td align="left">31</td><td>Yes</td><td>Yes</td></tr><tr valign="top"><td>3/007</td><td>F</td><td align="left">53</td><td align="left">136</td><td>Yes</td><td align="left">56</td><td>Yes</td><td>Yes</td></tr><tr valign="top"><td>4/008</td><td>F</td><td align="left">60</td><td align="left">132</td><td>Yes</td><td align="left">39</td><td>Yes</td><td>Yes</td></tr><tr valign="top"><td>5/010</td><td>F</td><td align="left">53</td><td align="left">77</td><td>Yes</td><td align="left">44</td><td>Yes</td><td>No</td></tr><tr valign="top"><td>6/012</td><td>M</td><td align="left">47</td><td align="left">91</td><td>Yes</td><td align="left">55</td><td>Yes</td><td>No</td></tr><tr valign="top"><td>7/014</td><td>F</td><td align="left">56</td><td align="left">94</td><td>Yes</td><td align="left">48</td><td>Yes</td><td>No</td></tr><tr valign="top"><td>8/015</td><td>F</td><td align="left">39</td><td align="left">97</td><td>Yes</td><td align="left">62</td><td>Yes</td><td>No</td></tr><tr valign="top"><td colspan="8">Low altitude</td></tr><tr valign="top"><td>9/001</td><td>F</td><td align="left">66</td><td align="left">101</td><td>Yes</td><td align="left">54</td><td>Yes</td><td>No</td></tr><tr valign="top"><td>10/002</td><td>M</td><td align="left">60</td><td align="left">115</td><td>Yes</td><td align="left">44</td><td>Yes</td><td>Yes</td></tr><tr valign="top"><td>11/004</td><td>M</td><td align="left">67</td><td align="left">113</td><td>No</td><td align="left">45</td><td>Yes</td><td>Yes</td></tr><tr valign="top"><td>12/005</td><td>F</td><td align="left">63</td><td align="left">86</td><td>Yes</td><td align="left">50</td><td>Yes</td><td>Yes</td></tr><tr valign="top"><td>13/009</td><td>F</td><td align="left">55</td><td align="left">107</td><td>Yes</td><td align="left">44</td><td>Yes</td><td>Yes</td></tr><tr valign="top"><td>14/011</td><td>M</td><td align="left">69</td><td align="left">139</td><td>Yes</td><td align="left">48</td><td>Yes</td><td>Yes</td></tr></tbody></table><table-wrap-foot><p>
<italic>Abbreviations</italic>: <italic>M</italic> male, <italic>F</italic> female, <italic>TG</italic> triglycerides, <italic>HDL-C</italic> high density lipoprotein cholesterol.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Anthropometric, body composition and cardiovascular measurements</title><p>On the day of arrival (day 0), baseline examinations (T<sub>0</sub>) were carried out; past medical history was taken and anthropometric data were collected. In the evening of day 0, information was given to participants on how exactly the study will be performed. The next morning (day 1), after an overnight fast, blood samples were collected before training started. Assessments and blood sample collection were repeated on day 14, two days after the last training session on day 12.</p><p>Body mass was assessed with a digital scale; body composition as percent body fat was measured using bioelectrical impendance analysis (both, OMRON Karada Scan BF 511). Body mass index (BMI) was determined as the individual&#x02019;s body mass divided by the square of the height &#x02013; with the value given in units of kg/m<sup>2</sup>. Waist circumference was measured in centimeters (cm) with a tape ruler between the lower rib margin and the iliac crest, at the end of expiration. Arterial blood pressure was measured (BOSO Medicus Family Automated Device; mmHg) two times in five minutes while the participant was seated; for analysis, the mean of the two measurements was used. Resting heart rate was measured as beats per minute (bpm) while the individual was seated after resting for 5&#x000a0;minutes. The maximal heart rate for each participant was assessed in a standard stress test performed at baseline with a bicycle ergometer. Age- and sex-dependent maximum VO<sub>2</sub> was deduced from maximum ergometer watts as read from a standardized nomogram.</p><p>Blood samples were taken before breakfast at 7:00&#x000a0;a.m., immediately cooled, transported to the nearest hospital laboratory with a maximum transportation time of 45&#x000a0;minutes, centrifuged and frozen. Samples were stored at &#x02212;80&#x000b0;C until analysis. Thereafter, subjects started their training sessions.</p><p>Blood samples taken on day 14 were handled as on day 1, i.e. at 7:00&#x000a0;a.m. before breakfast; cycle ergometer testing and T<sub>1</sub> examinations of all 14 subjects were both also done on day 14 at the study sites. Exercise testing on a bicycle ergometer up to maximum physical exhaustion was then repeated at the altitude of 300&#x000a0;m in all study subjects.</p></sec><sec id="Sec6"><title>Laboratory measurements</title><p>Blood samples were collected in heparinized tubes, immediately centrifuged at 4&#x000b0;C and the plasma aliquots obtained were frozen and stored at &#x02212;80&#x000b0;C for analysis at a later date. Parameters of lipid metabolism, glucose metabolism and inflammation were tested. C-reactive protein (CRP), free fatty acids, total cholesterol (TC), TG, and HDL-C measurements were performed on the automated clinical chemistry analyzer (ADVIA 1800; Siemens Healthcare Diagnostics, Eschborn, Germany). The inter-assay coefficients of variation were 0.9, 1.6, 1.4, 2.0 and 0.9%, respectively. Immunoassay systems (ADVIA Centaur) were used to measure plasma levels of insulin and C-peptide with inter-assay coefficients of variation of 2.8 and 3.2%, respectively. Immunoenzyme analysis (sandwich ELISA) was used to measure concentrations of total plasma leptin (DGR, Siemens BEP) and plasma adiponectin (BioVendor, Siemens BEP). The inter-assay coefficients of variation were 11.5 and 7.0% for leptin and adiponectin, respectively. Plasma glucose concentrations were measured using a chemistry-Immuno analyzer (Olympus AU2700&#x02122;); the inter-assay coefficient of variation was 1.8%.</p></sec><sec id="Sec7"><title>Sample size and statistical analysis</title><p>Sample size was calculated considering a repeated measure ANOVA, setting the significance level to &#x003b1;=5%, the power to &#x003b2;=80%, the correlation among repeated measures to &#x003c1;=0.75 and setting to 0.08 (moderate effect size) the minimum detectable effect sizes (partial eta-squared) for the within factor (pre/post training) and the within-between interaction (altitude &#x000d7; training). The required total sample size is 7 subjects per group.</p><p>Two-way repeated measures ANOVA (with main effects of altitude and training, and altitude &#x000d7; training interaction) was performed, followed by pairwise comparisons when one of the ANOVA terms was statistically significant (p&#x02009;&#x0003c;&#x02009;0.05). The statistical test used to compare pre and post measures was the t-test for paired samples. The pre/post relative change for TG and leptin measurements was calculated as follows:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \Delta \mathrm{X}\%=100\frac{{\mathrm{X}}_1\hbox{-} {\mathrm{X}}_0}{{\mathrm{X}}_0}, $$\end{document}</tex-math><mml:math id="M2"><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi mathvariant="normal">X</mml:mi><mml:mo mathvariant="normal">%</mml:mo><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">X</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>&#x02010;</mml:mo><mml:msub><mml:mi mathvariant="normal">X</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:msub><mml:mi mathvariant="normal">X</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfrac><mml:mtext>,</mml:mtext></mml:math><graphic xlink:href="13104_2015_1066_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p><p>where X<sub>0</sub> and X<sub>1</sub> were the values of the outcome X measured at baseline and at the end of the training program. Association between TG and leptin pre-post relative changes was estimated using the Spearman&#x02019;s rank correlation coefficient.</p><p>Effects were considered statistically significant at p&#x02009;&#x0003c;&#x02009;0.05 and borderline significant for p between 0.05 and 0.10. Statistical analyses were performed using R (version 3.1.1; R Foundation for Statistical Computing, Vienna, Austria) statistical software.</p></sec></sec><sec id="Sec8" sec-type="results"><title>Results</title><p>All 14 of the study subjects (mean age: 55.8&#x000a0;years, range: 39&#x02013;69 years, 6 males and 8 females) diagnosed with MetS who participated in the physical training protocol completed the program. Study participants assigned to the 1,900&#x000a0;m altitude group (n&#x02009;=&#x02009;8) were 3 men and 5 women aged 50.1&#x02009;&#x000b1;&#x02009;7.8&#x000a0;years (mean&#x02009;&#x000b1;&#x02009;standard deviation, range 39&#x02013;60), those of the 300&#x000a0;m altitude group (n&#x02009;=&#x02009;6) were 3 men and 3 women aged 63.3&#x02009;&#x000b1;&#x02009;5.2&#x000a0;years (range 55&#x02013;69).</p><p>Quantitative data on the training are given in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Data on the anthropometric, cardiovascular, and the biochemical profile of the subjects before and after the cardiovascular physical training at low or moderate altitude are given in Tables&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>. Effect sizes and statistical significance of main effects and interaction effect for altitude and training are also reported.<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Characteristics of the 2-week outdoor hiking intervention at low and moderate altitudes</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Characteristics</bold>
</th><th>
<bold>Low altitude</bold>
</th><th>
<bold>High altitude</bold>
</th></tr></thead><tbody><tr valign="top"><td>
<bold>Walking distance (meter)</bold>
</td><td align="left">39,500</td><td align="left">39,000</td></tr><tr valign="top"><td>
<bold>Exercise duration (min)</bold>
</td><td align="left">1,440</td><td align="left">1,440</td></tr><tr valign="top"><td>
<bold>Walking speed (km/h)</bold>
</td><td align="left">1.65</td><td align="left">1.62</td></tr><tr valign="top"><td>
<bold>Walking elevation gain (meter)</bold>
</td><td align="left">2.030</td><td align="left">2.054</td></tr></tbody></table></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>
<bold>Mean values for anthropometric and physiological variables, before (T</bold>
<sub><bold>0</bold></sub>
<bold>) and after (T</bold>
<sub><bold>1</bold></sub>
<bold>) the training program in the low (N=6) and moderate (N=8) altitude study groups</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Variable</bold>
</th><th colspan="2">
<bold>Low altitude</bold>
</th><th colspan="2">
<bold>Moderate altitude</bold>
</th><th colspan="2">
<bold>Altitude</bold>
</th><th colspan="2">
<bold>Training</bold>
</th><th colspan="2">
<bold>Altitude x Training</bold>
</th></tr><tr valign="top"><th/><th>
<bold>T</bold>
<sub><bold>0</bold></sub>
</th><th>
<bold>T</bold>
<sub><bold>1</bold></sub>
</th><th>
<bold>T</bold>
<sub><bold>0</bold></sub>
</th><th>
<bold>T</bold>
<sub><bold>1</bold></sub>
</th><th>
<bold>&#x003b7;</bold>
<sup><bold>2</bold></sup>
<sub><bold><italic>P</italic></bold></sub>
</th><th>
<bold>P</bold>
</th><th>
<bold>&#x003b7;</bold>
<sup><bold>2</bold></sup>
<sub><bold><italic>P</italic></bold></sub>
</th><th>
<bold>P</bold>
</th><th>
<bold>&#x003b7;</bold>
<sup><bold>2</bold></sup>
<sub><bold><italic>P</italic></bold></sub>
</th><th>
<bold>P</bold>
</th></tr></thead><tbody><tr valign="top"><td>
<bold>Body mass (kg)</bold>
</td><td align="left">88.6 &#x000b1; 20.2</td><td align="left">89.3 &#x000b1; 18.4</td><td align="left">91.8 &#x000b1; 22.5</td><td align="left">91.2 &#x000b1; 22.7</td><td align="left">0.004</td><td align="left">0.829</td><td align="left">0.000</td><td align="left">0.966</td><td align="left">0.130</td><td align="left">0.206</td></tr><tr valign="top"><td>
<bold>BMI (kg/m2)</bold>
</td><td align="left">32.3 &#x000b1; 4.2</td><td align="left">32.6 &#x000b1; 3.4</td><td align="left">31.1 &#x000b1; 5.3</td><td align="left">30.9 &#x000b1; 5.4</td><td align="left">0.024</td><td align="left">0.594</td><td align="left">0.005</td><td align="left">0.806</td><td align="left">0.157</td><td align="left">0.469</td></tr><tr valign="top"><td>
<bold>WC (cm)</bold>
</td><td align="left">110.2 &#x000b1; 17.6</td><td align="left">108.7 &#x000b1; 16</td><td align="left">109.2 &#x000b1; 22</td><td align="left">104.0 &#x000b1; 18.4</td><td align="left">0.013</td><td align="left">0.701</td><td align="left">0.159</td><td align="left">0.158</td><td align="left">0.077</td><td align="left">0.338</td></tr><tr valign="top"><td>
<bold>Body fat (%)</bold>
</td><td align="left">37.8 &#x000b1; 6.4</td><td align="left">36.5 &#x000b1; 8.2</td><td align="left">37.5 &#x000b1; 7.5</td><td align="left">36.9 &#x000b1; 7.0</td><td align="left">0.000</td><td align="left">0.990</td><td align="left">0.158</td><td align="left">0.160</td><td align="left">0.021</td><td align="left">0.621</td></tr><tr valign="top"><td>
<bold>Visceral fat (%)</bold>
</td><td align="left">16.0 &#x000b1; 6.4</td><td align="left">16.0 &#x000b1; 6.3</td><td align="left">12.2 &#x000b1; 4.9</td><td align="left">12.0 &#x000b1; 5.1</td><td align="left">0.120</td><td align="left">0.226</td><td align="left">0.058</td><td align="left">0.408</td><td align="left">0.058</td><td align="left">0.408</td></tr><tr valign="top"><td>
<bold>Muscle mass (%)</bold>
</td><td align="left">26.7 &#x000b1; 3.2</td><td align="left">28.6 &#x000b1; 5.3</td><td align="left">27.5 &#x000b1; 3.7</td><td align="left">27.9 &#x000b1; 3.6</td><td align="left">0.000</td><td align="left">0.974</td><td align="left">0.190</td><td align="left">0.119</td><td align="left">0.100</td><td align="left">0.271</td></tr><tr valign="top"><td>
<bold>Syst. BP (mmHg)</bold>
</td><td align="left">158.2 &#x000b1; 21.8</td><td align="left">143.7 &#x000b1; 18.1</td><td align="left">134.2 &#x000b1; 20.9</td><td align="left">138.1 &#x000b1; 10.2</td><td align="left">0.180</td><td align="left">0.131</td><td align="left">0.162</td><td align="left">0.153</td><td align="left">0.367</td><td align="left">0.022</td></tr><tr valign="top"><td>
<bold>Diast. BP (mmHg)</bold>
</td><td align="left">88.7 &#x000b1; 10.0</td><td align="left">85.5 &#x000b1; 8.1</td><td align="left">85.9 &#x000b1; 9.6</td><td align="left">86.9 &#x000b1; 6.8</td><td align="left">0.002</td><td align="left">0.865</td><td align="left">0.019</td><td align="left">0.640</td><td align="left">0.066</td><td align="left">0.375</td></tr><tr valign="top"><td>
<bold>Max. syst. BP (mmHg)</bold>
</td><td align="left">212.3 &#x000b1; 25.9</td><td align="left">187.5 &#x000b1; 14.7</td><td align="left">181.8 &#x000b1; 33.4</td><td align="left">184.3 &#x000b1; 24.4</td><td align="left">0.118</td><td align="left">0.250</td><td align="left">0.340</td><td align="left">0.036</td><td align="left">0.397</td><td align="left">0.021</td></tr><tr valign="top"><td>
<bold>Resting HR (bpm)</bold>
</td><td align="left">68.2 &#x000b1; 6.8</td><td align="left">65.3 &#x000b1; 7.9</td><td align="left">75.8 &#x000b1; 11.7</td><td align="left">71.2 &#x000b1; 10.9</td><td align="left">0.148</td><td align="left">0.174</td><td align="left">0.146</td><td align="left">0.177</td><td align="left">0.009</td><td align="left">0.750</td></tr><tr valign="top"><td>
<bold>Max. HR (bpm)</bold>
</td><td align="left">143.0 &#x000b1; 15.2</td><td align="left">144.7 &#x000b1; 20.9</td><td align="left">154.1 &#x000b1; 22.6</td><td align="left">148.9 &#x000b1; 22.9</td><td align="left">0.041</td><td align="left">0.508</td><td align="left">0.033</td><td align="left">0.550</td><td align="left">0.113</td><td align="left">0.261</td></tr><tr valign="top"><td>
<bold>Age-adjust. max. CF (%)</bold>
</td><td align="left">92.2 &#x000b1; 11.1</td><td align="left">95.3 &#x000b1; 14.2</td><td align="left">90.3 &#x000b1; 11.6</td><td align="left">91.0 &#x000b1; 9.7</td><td align="left">0.021</td><td align="left">0.633</td><td align="left">0.140</td><td align="left">0.207</td><td align="left">0.061</td><td align="left">0.415</td></tr><tr valign="top"><td>
<bold>Power (W=J/s)</bold>
</td><td align="left">133.3 &#x000b1; 25.8</td><td align="left">138.3 &#x000b1; 36.0</td><td align="left">189.3 &#x000b1; 82.7</td><td align="left">197.1 &#x000b1; 102.6</td><td align="left">0.162</td><td align="left">0.173</td><td align="left">0.064</td><td align="left">0.404</td><td align="left">0.003</td><td align="left">0.851</td></tr><tr valign="top"><td>
<bold>VO</bold>
<sub><bold>2</bold></sub>
<bold>max (ml/min)</bold>
</td><td align="left">1754 &#x000b1; 383.8</td><td align="left">1816 &#x000b1; 513.9</td><td align="left">2335 &#x000b1; 1058.4</td><td align="left">2417 &#x000b1; 1231.7</td><td align="left">0.106</td><td align="left">0.255</td><td align="left">0.079</td><td align="left">0.331</td><td align="left">0.002</td><td align="left">0.887</td></tr></tbody></table><table-wrap-foot><p>Effect sizes from a 2-way repeated measures ANOVA: main effect of altitude, main effect of training and altitude-training interaction.</p><p>Data are mean &#x000b1; standard deviation; &#x003b7;<sup>2</sup>
<sub><italic>P</italic></sub> = effect size (partial eta squared; &#x02018;small&#x02019; effect size, 0.01 &#x0003c; &#x003b7;<sup>2</sup>
<sub><italic>P</italic></sub> &#x02264; 0.06; &#x02018;medium&#x02019; effect size, 0.06 &#x0003c; &#x003b7;<sup>2</sup>
<sub><italic>P</italic></sub> &#x02264; 0.14; &#x02018;large&#x02019; effect size, &#x003b7;<sup>2</sup>
<sub><italic>P</italic></sub> &#x0003e; 0.14); P = significance level of the F statistic; N = number; T = time point; BMI = body mass index; WC = waist circumference; Max. syst. BP = maximum systolic blood pressure; Diast. BP = diastolic blood pressure; HR = heart rate; bpm = beats per minute; Max. = maximum; Age-adjust. = age-adjusted; CF = cardiac frequency.</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>
<bold>Mean values for blood lipid parameters before (T</bold>
<sub><bold>0</bold></sub>
<bold>) and after (T</bold>
<sub><bold>1</bold></sub>
<bold>) the training program in the low (N=6) and moderate (N=8) altitude study groups</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Variable</bold>
</th><th colspan="2">
<bold>Low altitude</bold>
</th><th colspan="2">
<bold>Moderate altitude</bold>
</th><th colspan="2">
<bold>Altitude</bold>
</th><th colspan="2">
<bold>Training</bold>
</th><th colspan="2">
<bold>Altitude &#x000d7; training</bold>
</th></tr><tr valign="top"><th/><th>
<bold>T</bold>
<sub><bold>0</bold></sub>
</th><th>
<bold>T</bold>
<sub><bold>1</bold></sub>
</th><th>
<bold>T</bold>
<sub><bold>0</bold></sub>
</th><th>
<bold>T</bold>
<sub><bold>1</bold></sub>
</th><th>
<bold>&#x003b7;</bold>
<sup><bold>2</bold></sup>
<sub><bold><italic>P</italic></bold></sub>
</th><th>
<bold>P</bold>
</th><th>
<bold>&#x003b7;</bold>
<sup><bold>2</bold></sup>
<sub><bold><italic>P</italic></bold></sub>
</th><th>
<bold>P</bold>
</th><th>
<bold>&#x003b7;</bold>
<sup><bold>2</bold></sup>
<sub><bold><italic>P</italic></bold></sub>
</th><th>
<bold>P</bold>
</th></tr></thead><tbody><tr valign="top"><td>
<bold>Total cholesterol (mg/dl)</bold>
</td><td align="left">195.5 &#x000b1; 29.4</td><td align="left">188.8 &#x000b1; 20.2</td><td align="left">206.6 &#x000b1; 36</td><td align="left">179.9 &#x000b1; 40.4</td><td align="left">0.000</td><td align="left">0.950</td><td align="left">0.357</td><td align="left">0.024</td><td align="left">0.167</td><td align="left">0.147</td></tr><tr valign="top"><td>
<bold>HDL-C (mg/dl)</bold>
</td><td align="left">47.5 &#x000b1; 4.0</td><td align="left">47.8 &#x000b1; 7.7</td><td align="left">46.6 &#x000b1; 10.6</td><td align="left">47.0 &#x000b1; 11.6</td><td align="left">0.002</td><td align="left">0.866</td><td align="left">0.011</td><td align="left">0.716</td><td align="left">0.000</td><td align="left">0.983</td></tr><tr valign="top"><td>
<bold>LDL-C (mg/dl)</bold>
</td><td align="left">145.2 &#x000b1; 30.8</td><td align="left">131.7 &#x000b1; 23.6</td><td align="left">145.6 &#x000b1; 33.3</td><td align="left">120.2 &#x000b1; 37.4</td><td align="left">0.010</td><td align="left">0.734</td><td align="left">0.353</td><td align="left">0.025</td><td align="left">0.048</td><td align="left">0.450</td></tr><tr valign="top"><td>
<bold>TG (mg/dl)</bold>
</td><td align="left">117.5 &#x000b1; 48.5</td><td align="left">121.5 &#x000b1; 31.0</td><td align="left">186.4 &#x000b1; 93.1</td><td align="left">126.8 &#x000b1; 58.8</td><td align="left">0.101</td><td align="left">0.269</td><td align="left">0.233</td><td align="left">0.080</td><td align="left">0.284</td><td align="left">0.050</td></tr><tr valign="top"><td>
<bold>Free fatty acids (mg/dl)</bold>
</td><td align="left">13.6 &#x000b1; 5.9</td><td align="left">12.8 &#x000b1; 8.3</td><td align="left">11.5 &#x000b1; 5.5</td><td align="left">13.6 &#x000b1; 4.8</td><td align="left">0.003</td><td align="left">0.846</td><td align="left">0.025</td><td align="left">0.590</td><td align="left">0.106</td><td align="left">0.257</td></tr><tr valign="top"><td>
<bold>Adiponectin (mg/l)</bold>
</td><td align="left">10.1 &#x000b1; 2.8</td><td align="left">9.1 &#x000b1; 3.1</td><td align="left">9.5 &#x000b1; 2.9</td><td align="left">8.1 &#x000b1; 2.0</td><td align="left">0.025</td><td align="left">0.591</td><td align="left">0.642</td><td>&#x0003c;0.001</td><td align="left">0.027</td><td align="left">0.578</td></tr><tr valign="top"><td>
<bold>Leptin (&#x003bc;g/l)</bold>
</td><td align="left">11.2 &#x000b1; 5.3</td><td align="left">11.8 &#x000b1; 5.6</td><td align="left">11.2 &#x000b1; 9.1</td><td align="left">8.2 &#x000b1; 7.3</td><td align="left">0.018</td><td align="left">0.649</td><td align="left">0.108</td><td align="left">0.251</td><td align="left">0.217</td><td align="left">0.093</td></tr><tr valign="top"><td>
<bold>Insulin (U/l)</bold>
</td><td align="left">16.8 &#x000b1; 10.2</td><td align="left">18.3 &#x000b1; 9.8</td><td align="left">14.7 &#x000b1; 5.8</td><td align="left">15.7 &#x000b1; 8.0</td><td align="left">0.026</td><td align="left">0.579</td><td align="left">0.041</td><td align="left">0.486</td><td align="left">0.003</td><td align="left">0.859</td></tr><tr valign="top"><td>
<bold>Glucose (mg/dl)</bold>
</td><td align="left">107.3 &#x000b1; 23.5</td><td align="left">105.8 &#x000b1; 16.9</td><td align="left">104.9 &#x000b1; 18.1</td><td align="left">103.3 &#x000b1; 20.3</td><td align="left">0.005</td><td align="left">0.809</td><td align="left">0.020</td><td align="left">0.628</td><td align="left">0.000</td><td align="left">0.985</td></tr><tr valign="top"><td>
<bold>C-peptide (U/l)</bold>
</td><td align="left">3.6 &#x000b1; 1.2</td><td align="left">3.5 &#x000b1; 1.0</td><td align="left">3.5 &#x000b1; 1.1</td><td align="left">3.3 &#x000b1; 1.3</td><td align="left">0.005</td><td align="left">0.818</td><td align="left">0.045</td><td align="left">0.467</td><td align="left">0.006</td><td align="left">0.786</td></tr><tr valign="top"><td>
<bold>C-reactive protein (mg/dl)</bold>
</td><td align="left">0.20 &#x000b1; 0.14</td><td align="left">0.21 &#x000b1; 0.11</td><td align="left">0.43 &#x000b1; 0.40</td><td align="left">0.35 &#x000b1; 0.36</td><td align="left">0.128</td><td align="left">0.209</td><td align="left">0.021</td><td align="left">0.652</td><td align="left">0.026</td><td align="left">0.580</td></tr></tbody></table><table-wrap-foot><p>Effect sizes from a 2-way repeated measures ANOVA: main effect of altitude, main effect of training and altitude-training interaction.</p><p>Data are mean &#x000b1; standard deviation; &#x003b7;<sup>2</sup>
<sub><italic>P</italic></sub> = effect size (partial eta squared; &#x02018;small&#x02019; effect size, 0.01 &#x0003c;&#x003b7;<sup>2</sup>
<sub><italic>P</italic></sub> &#x02264; 0.06; &#x02018;medium&#x02019; effect size, 0.06 &#x0003c; &#x003b7;<sup>2</sup>
<sub><italic>P</italic></sub> &#x02264; 0.14; &#x02018;large&#x02019; effect size, &#x003b7;<sup>2</sup>
<sub><italic>P</italic></sub> &#x0003e; 0.14); P = significance level of the F statistic; N = number; T = time point; BMI = body mass index; WC = waist circumference; Max. syst. BP = maximum systolic blood pressure; Diast. BP = diastolic blood pressure; HR = heart rate; bpm = beats per minute; Max. = maximum; Age-adjust. = age-adjusted; CF = cardiac frequency.</p></table-wrap-foot></table-wrap></p><p>Significant altitude &#x000d7; training interactions with large effect size were seen for systolic blood pressure at rest and maximum systolic blood pressure in the cycle ergometer test (p&#x02009;=&#x02009;0.022 and 0.021, respectively; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Pre-post pairwise comparisons revealed that mean systolic blood pressure at rest and maximum systolic blood pressure in ergometry were reduced by training at low altitude (p&#x02009;=&#x02009;0.040 and p&#x02009;=&#x02009;0.036, respectively) but not at moderate altitude (p&#x02009;=&#x02009;0.424 and 0.792, respectively).</p><p>Borderline significant altitude x training interactions with large effect sizes were noted for TG and leptin (p&#x02009;=&#x02009;0.050 and p&#x02009;=&#x02009;0.093, respectively; Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Pre-post comparisons of these parameters showed significant reductions at moderate (p&#x02009;=&#x02009;0.025 and 0.015, respectively) but not at low altitude (p&#x02009;=&#x02009;0.838 and 0.765, respectively).</p><p>Large and statistically significant main effects of training were observed for levels of total cholesterol, LDL-C and adiponectin (p&#x02009;=&#x02009;0.024, p&#x02009;=&#x02009;0.025 and p&#x02009;&#x0003c;&#x02009;0.001, respectively; Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Training significantly reduced adiponectin levels both at moderate (p&#x02009;=&#x02009;0.005) and low altitude (p&#x02009;=&#x02009;0.044). Total cholesterol and LDL-C showed significant pre-post reductions of mean levels only for moderate altitude (p&#x02009;&#x0003c;&#x02009;0.001).</p><p>Using repeated measures mixed models (also known as hierarchical random effects models), we re-evaluated the differences in the distribution of the study parameters between the two altitude groups, correcting for the VO<sub>2</sub>max baseline values. Each model has the following X covariates: altitude group (low vs moderate), time point (pre vs. post training), &#x0201c;altitude &#x000d7; time&#x0201d; interaction and VO<sub>2</sub>max baseline values. These analyses largely confirmed the previous results.</p><p>Relative changes of triglyceride and leptin levels showed a statistically significant correlation (Spearman &#x003c1;&#x02009;=&#x02009;0.71, p&#x02009;=&#x02009;0.006, Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Pre- and post-training change (percentage) in leptin and triglyceride levels.</bold>
</p></caption><graphic xlink:href="13104_2015_1066_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec9" sec-type="discussion"><title>Discussion</title><p>The main new finding of the current study is that a 2-week hiking vacation at moderate altitude was more effective in acutely reducing elevated plasma leptin levels of patients with MetS than a comparable hiking vacation at low altitude, and that this change is correlated with reductions of triglyceride levels. The study additionally suggests that a short-term training intervention in patients with MetS reduces total cholesterol and LDL-C levels even in the absence any dietary restrictions.</p><p>It is worth pointing out that these findings have to be interpreted with caution due to the preliminary nature and some intrinsic limitations of the present study. Firstly, the limited sample size allows to detect only moderate and large effects for the within (training) effect and the within-between (training &#x000d7; altitude) interaction. Secondly, a moderate imbalance is present in the assigned number of subjects in the low vs. moderate altitude groups (n&#x02009;=&#x02009;6 and 8, respectively). Thirdly, due to the small sample size, randomization did not achieve complete balance at baseline for the distribution of gender and age in the low vs. moderate altitude groups; however, the imbalance of physiological and blood lipid parameters at baseline in the two altitude groups is not a problem. The pre/post design of the study and the repeated measures analysis of variance allowed efficient removal of the effect of imbalance at T<sub>0</sub>.</p><p>The present pilot study has some interesting results on the effects of training at different altitudes on the carbohydrate and lipid parameters in MetS. For firm conclusions, a future randomized controlled trial with an adequate sample size is needed.</p><p>Low intense physical exercise in normobaric hypoxia leads to more weight loss in obese people than low intense physical exercise in normobaric sham hypoxia [<xref ref-type="bibr" rid="CR37">37</xref>]. In patients with MetS, physical training under hypoxic and hypobaric conditions of moderate altitude beneficially affects not only metabolic parameters but also anthropomorphic and hemodynamic parameters [<xref ref-type="bibr" rid="CR31">31</xref>-<xref ref-type="bibr" rid="CR34">34</xref>]. In the current study, anthropomorphic and body composition parameters did not significantly change in either study group (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Most likely this is due to the small sample size, but may also be related to the short intervention time of 2&#x000a0;weeks as well as the fact that training intensity was designed to be moderate and suitable for untrained people with metabolic and cardiovascular risk factors. Improved cardiorespiratory fitness has been observed in a study with similar design and comparable training intensity; however, the duration of intervention was 3&#x000a0;weeks as compared to 2&#x000a0;weeks of the present study [<xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref>]. Moreover, as no nutritionally standardized menus were offered, it may well be that caloric intake may have been increased during the hiking vacation period thus reducing the effects of training on body weight and composition.</p><p>Dose&#x02013;response relationships between exercise training volume and blood lipid changes have been intensively investigated in the past. Data suggest that exercise can beneficially alter blood lipids at low training volumes, and HDL-C and TG are more amenable to exercise than others with greater exercise training duration and caloric expenditure associated with more marked improvements [<xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref>]. Favorable changes of HDL-C and TG levels by moderate endurance training (70% VO<sub>2</sub>max, 30&#x000a0;min/day, 3&#x02013;4 days/week) of up to eight weeks duration have been observed beyond a duration of three weeks [<xref ref-type="bibr" rid="CR39">39</xref>]. In healthy adults, three weeks of daily running of 6.5&#x000a0;km at 19&#x000a0;km/h (high intensity) or 3.2&#x000a0;km at 10&#x000a0;km/h (low intensity) increased HDL-C significantly by 10% in both groups and reduced TG by 37% and 28% in the high and low intensity group, respectively [<xref ref-type="bibr" rid="CR40">40</xref>]. In a tree-week&#x000a0;cycle ergometry study in 12 healthy males exercising daily at 58% of their maximal oxygen uptake for a mean of 116&#x000a0;min/day in order to induce a daily energy deficit of 1000&#x000a0;kcal, plasma TG decreased and HDL-C concentration increased significantly [<xref ref-type="bibr" rid="CR41">41</xref>]. Whether these improvements in lipid metabolism are the sole consequences of the short exercise programs remains questionable.</p><p>In the Austrian Moderate Altitude Study [<xref ref-type="bibr" rid="CR31">31</xref>], the effects of a 3-week exercise training program were investigated at 1,700&#x000a0;m altitude in subjects with metabolic syndrome that included 12 moderate-intensity guided hiking tours 4 times/week at 55-65% heart rate maximum with a total exercise time of 29&#x000a0;h; HDL-C levels increased significantly during the training program by day 19, whereas no changes were seen for TC and LDL-C levels; HDL-C levels returned to baseline levels 7 to 10&#x000a0;days after the training program [<xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref>]. An explanation for this observation may be that endurance exercise acutely lowered TG levels and increases HDL-C, a phenomenon known to occur for up to 48&#x000a0;h after acute exercise [<xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref>]. In our pilot study, the duration of comparable exercise intensity was shorter (two weeks) and blood samples were drawn 48&#x000a0;hours after the last training session when acute effects of exercise training probably have diminished but may not yet have entirely disappeared.</p><p>Exercise training and a single session of exercise exert distinct and interactive effects on lipids and lipoproteins [<xref ref-type="bibr" rid="CR44">44</xref>]. Single sessions of exercise transiently reduce serum TG which occurs after a delay of hours, is generally maximal on the day following exercise [<xref ref-type="bibr" rid="CR44">44</xref>-<xref ref-type="bibr" rid="CR47">47</xref>] and usually disappears until day 3 [<xref ref-type="bibr" rid="CR43">43</xref>]. The effect can be blunted when the energy and carbohydrate deficit induced by exercise is replaced during the hours post-exercise [<xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR49">49</xref>]. In the current pilot study, effects of the two-week exercise training program on fasting TG levels were assessed 48&#x000a0;hours after the last training session, when acute effects of the last training bout may not yet have entirely disappeared. Even though exercise-induced energy and carbohydrate deficit may have been sufficiently replaced in our study because dietary intake was not controlled, this remains as a possible confounding factor. Results, therefore, have to be interpreted with caution regarding acute vs. chronic exercise effects on lipid metabolism parameters.</p><p>Decreased leptin levels in response to exercise training are typically associated with reductions in body mass, BMI and body fat mass [<xref ref-type="bibr" rid="CR50">50</xref>-<xref ref-type="bibr" rid="CR53">53</xref>]. In one study of 9 middle-aged sedentary women without dietary restrictions, however, walking and/or running for 45&#x000a0;min 4 times/week at 85% heart rate maximum for a total of 12&#x000a0;weeks significantly reduced leptin levels by more than 17%, whereas body mass, body mass index and percent body fat mass were not significantly changed [<xref ref-type="bibr" rid="CR54">54</xref>]. Thus, our finding of significantly reduced leptin levels by a 2-week training intervention in the absence of significant changes in body weight and composition is not contradictory.</p><p>Altitude training can beneficially affect the metabolic system, and has the potential to serve as a non-pharmacological or recreational intervention regimen for correcting MetS [<xref ref-type="bibr" rid="CR55">55</xref>]. In our study, fasting plasma glucose, insulin and C-peptide levels were not significantly affected by the 2-week hiking vacation. This observation is compatible with previous findings showing that short-term moderate altitude hypoxia living and physical endurance training of 3&#x000a0;weeks or less can improve results of glucose tolerance testing but does not affect fasting glucose levels [<xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref>].</p><p>Effects of hypoxic training on parameters of lipid metabolism studied so far have been mixed. While improvements in total cholesterol (&#x02212;4.2% to &#x02212;30%) and LDL-C (&#x02212;2.6% to &#x02212;14.3%) have been reported as a result of hypoxic training, available evidence does not substantiate hypoxic training for the improvement of HDL-C and TG (for review, see [<xref ref-type="bibr" rid="CR55">55</xref>]). In the study subjects with MetS analyzed here, total cholesterol and low-density-lipoprotein cholesterol significantly improved upon 2 weeks of moderate endurance training (both, large effect size) with no significant changes in HDL-C levels. The observed decrease in triglyceride levels showed a borderline statistical significance that may be related to imbalance of baseline levels between the two study groups (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Significant findings including the correlation of triglyceride changes with leptin changes (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) confirm the effectiveness of hypoxic training on the modulation of dyslipidemia in MetS.</p><p>Increased triglyceride levels independently contribute to cardiovascular risk [<xref ref-type="bibr" rid="CR58">58</xref>]. This study&#x02019;s finding of reductions not only of total and low-density lipoprotein cholesterol but of potentially stronger reduction of triglyceride levels by training at moderate altitude is therefore of potential relevance to efforts at reducing cardiovascular risk. However, as mentioned before, the small sample size of the current study and baseline imbalances in triglyceride levels between the moderate and low altitude training groups may confound conclusions. In order to confirm the effectiveness of hypoxic training on the modulation of metabolic cardiovascular risk factors, plasma levels of leptin were therefore further assessed.</p><p>Mechanisms by which exercise training improves plasma HDL-C and TG are not entirely understood. Favorable effects of exercise on lipoprotein metabolism may be mediated by favorable changes in body weight and composition, as well as by enhancements in hepatic insulin sensitivity and blood flow, and increase in peripheral lipoprotein lipase (LPL) activity [<xref ref-type="bibr" rid="CR59">59</xref>]. Exercise training increases hepatic lipases and LPL activity in tissue and muscle. It is suggested that LPL and lower very-low-density lipoprotein (VLDL) and chylomicron TG levels are involved. These changes enhance reverse cholesterol transport and contribute to HDL maturity; TGs are exchanged for cholesterol esters in HDL and LDL and are hydrolyzed by lipases [<xref ref-type="bibr" rid="CR60">60</xref>]. Due to the low volume and intensity of exercise training in our pilot trial and uncontrolled dietary intake, significant changes in physical fitness, body weight and composition as well as parameters of glucose metabolism have not been observed, however, observed changes in blood lipids need to be confirmed in future studies.</p><p>Whereas the effect of exercise on adiponectin levels in healthy and obese subjects was conflicting in the available literature, increased plasma levels of leptin in obese, prediabetic, or MetS patients were consistently reduced by exercise, a finding largely independent of type and duration of exercise protocols tested [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p>Adipokine responses to exercise vary depending on the exercise intensity levels [<xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref>]. Acute and short-term bouts of exercise do not affect leptin levels in healthy individuals [<xref ref-type="bibr" rid="CR63">63</xref>] but can reduce leptin levels in diabetic patients [<xref ref-type="bibr" rid="CR52">52</xref>] who seem to be more responsive to the leptin lowering effects of exercise. Intensity and duration of exercise tested in the current study was defined by patient characteristics including sedentary life style and MetS, and the vacational setting, i.e. two weeks duration, respectively. In our study, results suggest that duration and intensity of physical exercise training tested may be sufficient because plasma leptin levels were significantly reduced in the moderate-altitude but not in the low-altitude group. As the percentage of reduction in plasma leptin levels was closely related to the percentage of reduction in triglyceride levels (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>), these observations corroborate the observed greater effectiveness of short-term training at moderate altitude as compared to low altitude on cardiovascular risk parameters of lipid metabolism in MetS. Leptin plasma levels were significantly reduced in daughters of patients with type 2 diabetes, who, in a 7-week training program, exercised a total of 1,450&#x000a0;min at 74% of their maximum heart rate [<xref ref-type="bibr" rid="CR64">64</xref>]. In our study, plasma leptin levels also fell in patients with MetS who completed a total of 1,440&#x000a0;min of exercise in a 2-week training program at a maximum heart rate between 55 and 65%. This suggests that potentially beneficial adipokine changes may be achieved in a concentrated 2-week training program even at a somewhat lower maximum heart rate than in previous studies when performed under hypoxic conditions.</p><p>Circulating leptin levels correlate with body mass index, blood pressure, total cholesterol, triglyceride, and inflammatory markers; these correlations persist also after body mass index adjustment [<xref ref-type="bibr" rid="CR65">65</xref>]. The mechanisms involved in the effects of exercise training under hypoxic and hypobaric conditions on plasma leptin and triglyceride levels that strongly correlate with each other remain speculative. Factors potentially contributing to the observed reduction of leptin levels by exercise training may include the effect of hypoxia itself, as serum leptin level decreases when altitude increases, and this association helped to explain the lower cardiovascular mortality rate at high altitude [<xref ref-type="bibr" rid="CR66">66</xref>]. Training at hypoxic conditions may increase the basal metabolic rate as the result of improved substrate utilization and mitochondrial oxidative capacity via signaling pathways that stimulate GLUT-4 transport [<xref ref-type="bibr" rid="CR67">67</xref>]. In addition, epinephrine levels increased as a result of hypoxic training [<xref ref-type="bibr" rid="CR68">68</xref>], which may give rise to increased glycolysis. Training at hypoxic conditions allows a higher relative intensity to be achieved, which would reduce the mechanical strain of higher workloads while gaining similar benefits [<xref ref-type="bibr" rid="CR69">69</xref>].</p><p>Serum leptin levels are correlated positively with insulin resistance, independent of body weight or adiposity, both in normoglycemic and in diabetic patients [<xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref>]. Since exercise training beneficially affects insulin resistance, mechanisms involved in leptin responses might be related. Many factors regulate leptin expression and secretion from adipocytes, including nutrients, steroid and thyroid hormones, and cytokines [<xref ref-type="bibr" rid="CR72">72</xref>]. Adipose tissue is richly innervated by sympathetic fibers driving lipolysis during fasting, cold exposure and exercise; beta-adrenergic stimulation decreases leptin release from fat cells [<xref ref-type="bibr" rid="CR73">73</xref>]. Muscle is a direct and indirect target of adipokines that regulate metabolism, and conversely, releases myokines like irisin, a hormone produced by skeletal muscle in response to exercise that can affect adipose function by various overlapping mechanisms including sympathetic nervous system-induced signaling specifically to brown adipose tissues [<xref ref-type="bibr" rid="CR73">73</xref>-<xref ref-type="bibr" rid="CR75">75</xref>]. Beyond local interaction between muscle and adipocytes by adipokines and myokines, circulating irisin predicts insulin resistance onset in association with weight regain and reflects body fat mass, suggesting that the irisin circulating levels are conditioned by adiposity level [<xref ref-type="bibr" rid="CR76">76</xref>]. If exercise-induced irisin might exert direct effects on leptin production and release from adipocytes is currently not known [<xref ref-type="bibr" rid="CR77">77</xref>]. Irisin levels have not been assessed in this pilot study but should be further investigated in the particular setting of non-pharmacologic exercise interventions in patients with MetS as it might be involved on its biological mechanism.</p><p>Carbohydrate and lipid metabolism are greatly influenced by diet. Observed differences between treatments at low and moderate altitude could be attributed to variation in food intake. Since the pilot study was intended to investigate metabolic effects of hiking during a 2-week vacation, the design was as pragmatic as possible. Therefore, daily dietary intake was not controlled. This is a limitation of the study and precludes mechanistic interpretations. It needs to be underlined that in studies investigating fat metabolism adaptions in response to exercise, as such diet control is of paramount importance and should become part of the actual study protocol.</p><p>Lack of documented quantitative data of training of the two intervention groups is another limitation.</p><p>Hiking vacations at moderate altitude may become an interesting non-pharmacological intervention in patients with MetS, as such an intervention of 2-to-3&#x000a0;weeks duration not only improved perceived health in individuals with MetS [<xref ref-type="bibr" rid="CR78">78</xref>] but also cardiovascular risk factors.</p></sec><sec id="Sec10" sec-type="conclusion"><title>Conclusions</title><p>Results of this small pilot study suggest that in patients with metabolic syndrome, a 2-week hiking vacation at moderate altitude may be more efficacious in improving parameters of dyslipidemia and circulating levels of adipokines than training at low altitude. Greater reductions of triglyceride and leptin levels in moderate altitude may suggest that metabolic responses to hypobaric and hypoxic conditions may translate into better short-term improvement of dyslipidemia and thus of MetS. Based on these preliminary observations, the efficacy and safety of hiking vacations at moderate altitude for improving diseases parameters in patients with MetS should to be further investigated in larger scale interventional trials.</p></sec></body><back><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>IG, GH, MS and CJW contributed to conception and design of the study, analysis and interpretation of data. IG, GH and AG performed data acquisition. IG and CJW drafted the manuscript and AG, MS and GH revised it critically for important intellectual content. All authors have given final approval of the manuscript to be published and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy and integrity of any part of the work are appropriately investigated and resolved.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The study was supported by a grant of the ESF European Social Fund (2/308/2010).</p><p>The authors wish to thank Doctor Susanne Kaser, Professor at the Medical University of Innsbruck, for fruitful discussion.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>KGMM</given-names></name><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name></person-group><article-title>Metabolic syndrome &#x02013; a new world-wide definition. A consensus statement from the international diabetes federation</article-title><source>Diabet Med</source><year>2006</year><volume>23</volume><fpage>469</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2006.01858.x</pub-id><pub-id pub-id-type="pmid">16681555</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Cholesterol Education Program</collab></person-group><article-title>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report</article-title><source>Circulation</source><year>2002</year><volume>106</volume><fpage>3143</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">12485966</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Eckel</surname><given-names>RH</given-names></name><name><surname>Grundy</surname><given-names>SM</given-names></name><name><surname>Zimmet</surname><given-names>PZ</given-names></name><name><surname>Cleeman</surname><given-names>JI</given-names></name><name><surname>Donato</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity</article-title><source>Circulation</source><year>2009</year><volume>120</volume><fpage>1640</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.192644</pub-id><pub-id pub-id-type="pmid">19805654</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-L&#x000f3;pez</surname><given-names>FR</given-names></name><name><surname>Chedraui</surname><given-names>P</given-names></name><name><surname>Gilbert</surname><given-names>JJ</given-names></name><name><surname>P&#x000e9;rez-Roncero</surname><given-names>G</given-names></name></person-group><article-title>Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women&#x02019;s health initiative era</article-title><source>Fertil Steril</source><year>2009</year><volume>92</volume><fpage>1171</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.06.032</pub-id><pub-id pub-id-type="pmid">19700149</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>K</given-names></name><name><surname>Chiodini</surname><given-names>P</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Lenzi</surname><given-names>A</given-names></name><name><surname>Giugliano</surname><given-names>D</given-names></name></person-group><article-title>Metabolic syndrome and risk of cancer: a systematic review and meta-analysis</article-title><source>Diabetes Care</source><year>2012</year><volume>35</volume><fpage>2402</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.2337/dc12-0336</pub-id><pub-id pub-id-type="pmid">23093685</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JW</given-names></name><name><surname>Caffrey</surname><given-names>JL</given-names></name><name><surname>Chang</surname><given-names>MH</given-names></name><name><surname>Lin</surname><given-names>YS</given-names></name></person-group><article-title>Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality&#x02013;cohort analysis from the third national health and nutrition examination survey</article-title><source>J Clin Endocrinol Metab</source><year>2010</year><volume>95</volume><fpage>4258</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1210/jc.2010-0332</pub-id><pub-id pub-id-type="pmid">20534759</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chedraui</surname><given-names>P</given-names></name><name><surname>P&#x000e9;rez-L&#x000f3;pez</surname><given-names>FR</given-names></name><name><surname>Bl&#x000fc;mel</surname><given-names>JE</given-names></name><name><surname>Hidalgo</surname><given-names>L</given-names></name><name><surname>Barriga</surname><given-names>J</given-names></name></person-group><article-title>Hyperglycemia in postmenopausal women screened for the metabolic syndrome is associated to increased sexual complaints</article-title><source>Gynecol Endocrinol</source><year>2010</year><volume>26</volume><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.3109/09513590903184092</pub-id><pub-id pub-id-type="pmid">19908936</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arita</surname><given-names>Y</given-names></name><name><surname>Kihara</surname><given-names>S</given-names></name><name><surname>Ouchi</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Miyagawa</surname><given-names>J</given-names></name><etal/></person-group><article-title>Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity</article-title><source>Biochem Biophys Res Commun</source><year>1999</year><volume>257</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1999.0255</pub-id><pub-id pub-id-type="pmid">10092513</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>L</given-names></name><name><surname>Zou</surname><given-names>C</given-names></name><name><surname>van der Westhuyzen</surname><given-names>DR</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name></person-group><article-title>Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><fpage>1824</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.2337/db07-0435</pub-id><pub-id pub-id-type="pmid">18375436</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuura</surname><given-names>F</given-names></name><name><surname>Oku</surname><given-names>H</given-names></name><name><surname>Koseki</surname><given-names>M</given-names></name><name><surname>Sandoval</surname><given-names>JC</given-names></name><name><surname>Yuasa-Kawase</surname><given-names>M</given-names></name><name><surname>Tsubakio-Yamamoto</surname><given-names>K</given-names></name><etal/></person-group><article-title>Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>358</volume><fpage>1091</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.05.040</pub-id><pub-id pub-id-type="pmid">17521614</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oku</surname><given-names>H</given-names></name><name><surname>Matsuura</surname><given-names>F</given-names></name><name><surname>Koseki</surname><given-names>M</given-names></name><name><surname>Sandoval</surname><given-names>JC</given-names></name><name><surname>Yuasa-Kawase</surname><given-names>M</given-names></name><name><surname>Tsubakio-Yamamoto</surname><given-names>K</given-names></name><etal/></person-group><article-title>Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver</article-title><source>FEBS Lett</source><year>2007</year><volume>581</volume><fpage>5029</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2007.09.038</pub-id><pub-id pub-id-type="pmid">17936760</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwashima</surname><given-names>Y</given-names></name><name><surname>Katsuya</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Ouchi</surname><given-names>N</given-names></name><name><surname>Ohishi</surname><given-names>M</given-names></name><name><surname>Sugimoto</surname><given-names>K</given-names></name><etal/></person-group><article-title>Hypoadiponectinemia is an independent risk factor for hypertension</article-title><source>Hypertension</source><year>2004</year><volume>43</volume><fpage>1318</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000129281.03801.4b</pub-id><pub-id pub-id-type="pmid">15123570</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryo</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Kihara</surname><given-names>S</given-names></name><name><surname>Kumada</surname><given-names>M</given-names></name><name><surname>Shibazaki</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Adiponectin as a biomarker of the metabolic syndrome</article-title><source>Circ J</source><year>2004</year><volume>68</volume><fpage>975</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1253/circj.68.975</pub-id><pub-id pub-id-type="pmid">15502375</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattu</surname><given-names>HS</given-names></name><name><surname>Randeva</surname><given-names>HS</given-names></name></person-group><article-title>Role of adipokines in cardiovascular disease</article-title><source>J Endocrinol</source><year>2013</year><volume>216</volume><fpage>T17</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1530/JOE-12-0232</pub-id><pub-id pub-id-type="pmid">23160967</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindler</surname><given-names>TH</given-names></name><name><surname>Cardenas</surname><given-names>J</given-names></name><name><surname>Prior</surname><given-names>JO</given-names></name><name><surname>Facta</surname><given-names>AD</given-names></name><name><surname>Kreissl</surname><given-names>MC</given-names></name><name><surname>Zhang</surname><given-names>XL</given-names></name><etal/></person-group><article-title>Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function</article-title><source>J Am Coll Cardiol</source><year>2006</year><volume>47</volume><fpage>1188</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2005.10.062</pub-id><pub-id pub-id-type="pmid">16545651</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruzdeva</surname><given-names>O</given-names></name><name><surname>Uchasova</surname><given-names>E</given-names></name><name><surname>Belik</surname><given-names>E</given-names></name><name><surname>Dyleva</surname><given-names>Y</given-names></name><name><surname>Shurygina</surname><given-names>E</given-names></name><name><surname>Barbarash</surname><given-names>O</given-names></name></person-group><article-title>Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance</article-title><source>BMC Cardiovasc Disord</source><year>2014</year><volume>14</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/1471-2261-14-7</pub-id><pub-id pub-id-type="pmid">24433403</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vissers</surname><given-names>D</given-names></name><name><surname>Hens</surname><given-names>W</given-names></name><name><surname>Taeymans</surname><given-names>J</given-names></name><name><surname>Baeyens</surname><given-names>JP</given-names></name><name><surname>Poortmans</surname><given-names>J</given-names></name><name><surname>Van Gaal</surname><given-names>L</given-names></name></person-group><article-title>The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e56415</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0056415</pub-id><pub-id pub-id-type="pmid">23409182</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattyn</surname><given-names>N</given-names></name><name><surname>Cornelissen</surname><given-names>VA</given-names></name><name><surname>Eshghi</surname><given-names>SR</given-names></name><name><surname>Vanhees</surname><given-names>L</given-names></name></person-group><article-title>The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials</article-title><source>Sports Med</source><year>2013</year><volume>43</volume><fpage>121</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1007/s40279-012-0003-z</pub-id><pub-id pub-id-type="pmid">23329606</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pescatello</surname><given-names>LS</given-names></name><name><surname>Blanchard</surname><given-names>BE</given-names></name><name><surname>Van Heest</surname><given-names>JL</given-names></name><name><surname>Maresh</surname><given-names>CM</given-names></name><name><surname>Gordish-Dressman</surname><given-names>H</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name></person-group><article-title>The metabolic syndrome and the immediate antihypertensive effects of aerobic exercise: a randomized control design</article-title><source>BMC Cardiovasc Disord</source><year>2008</year><volume>8</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.1186/1471-2261-8-12</pub-id><pub-id pub-id-type="pmid">18544158</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golbidi</surname><given-names>S</given-names></name><name><surname>Laher</surname><given-names>I</given-names></name></person-group><article-title>Exercise induced adipokine changes and the metabolic syndrome</article-title><source>J Diabetes Res</source><year>2014</year><volume>2014</volume><fpage>726861</fpage><pub-id pub-id-type="doi">10.1155/2014/726861</pub-id><pub-id pub-id-type="pmid">24563869</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>TY</given-names></name><name><surname>Ding</surname><given-names>SQ</given-names></name><name><surname>Liu</surname><given-names>JL</given-names></name><name><surname>Yu</surname><given-names>MT</given-names></name><name><surname>Jia</surname><given-names>JH</given-names></name><name><surname>Chai</surname><given-names>ZC</given-names></name><etal/></person-group><article-title>Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad</article-title><source>High Alt Med Biol</source><year>2007</year><volume>8</volume><fpage>88</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1089/ham.2007.1015</pub-id><pub-id pub-id-type="pmid">17584003</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ri-Li</surname><given-names>G</given-names></name><name><surname>Chase</surname><given-names>PJ</given-names></name><name><surname>Witkowski</surname><given-names>S</given-names></name><name><surname>Wyrick</surname><given-names>BL</given-names></name><name><surname>Stone</surname><given-names>JA</given-names></name><name><surname>Levine</surname><given-names>BD</given-names></name><etal/></person-group><article-title>Obesity: associations with acute mountain sickness</article-title><source>Ann Intern Med</source><year>2003</year><volume>139</volume><fpage>253</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-139-4-200308190-00007</pub-id><pub-id pub-id-type="pmid">12965980</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname><given-names>SJ</given-names></name><name><surname>Blume</surname><given-names>FD</given-names></name></person-group><article-title>Weight-loss and changes in body composition at high altitude</article-title><source>J Appl Physiol</source><year>1984</year><volume>57</volume><fpage>1580</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">6520055</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netzer</surname><given-names>NC</given-names></name><name><surname>Chytra</surname><given-names>R</given-names></name><name><surname>K&#x000fc;pper</surname><given-names>T</given-names></name></person-group><article-title>Low intense physical exercise in normobaric hypoxia leads to more weight loss in obese people than low intense physical exercise in normobaric sham hypoxia</article-title><source>Sleep Breath</source><year>2008</year><volume>12</volume><fpage>129</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1007/s11325-007-0149-3</pub-id><pub-id pub-id-type="pmid">18057976</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Workman</surname><given-names>C</given-names></name><name><surname>Basset</surname><given-names>FA</given-names></name></person-group><article-title>Post-metabolic response to passive normobaric hypoxic exposure in sedentary overweight males: a pilot study</article-title><source>Nutr Metab (Lond)</source><year>2012</year><volume>9</volume><fpage>103</fpage><pub-id pub-id-type="doi">10.1186/1743-7075-9-103</pub-id><pub-id pub-id-type="pmid">23157699</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>H</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name></person-group><article-title>Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><fpage>17462</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.1317158110</pub-id><pub-id pub-id-type="pmid">24101519</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howangyin</surname><given-names>KY</given-names></name><name><surname>Silvestre</surname><given-names>JS</given-names></name></person-group><article-title>Diabetes mellitus and ischemic diseases: molecular mechanisms of vascular repair dysfunction</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2014</year><volume>34</volume><fpage>1126</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.114.303090</pub-id><pub-id pub-id-type="pmid">24675660</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burtscher</surname><given-names>M</given-names></name></person-group><article-title>Effects of living at higher altitudes on mortality: a narrative review</article-title><source>Aging Dis</source><year>2013</year><volume>5</volume><fpage>274</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">25110611</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St&#x000f6;whas</surname><given-names>AC</given-names></name><name><surname>Latshang</surname><given-names>TD</given-names></name><name><surname>Lo Cascio</surname><given-names>CM</given-names></name><name><surname>Lautwein</surname><given-names>S</given-names></name><name><surname>Stadelmann</surname><given-names>K</given-names></name><name><surname>Tesler</surname><given-names>N</given-names></name><etal/></person-group><article-title>Effects of acute exposure to moderate altitude on vascular function, metabolism and systemic inflammation</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e70081</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0070081</pub-id><pub-id pub-id-type="pmid">23936377</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haufe</surname><given-names>S</given-names></name><name><surname>Wiesner</surname><given-names>S</given-names></name><name><surname>Engeli</surname><given-names>S</given-names></name><name><surname>Luft</surname><given-names>FC</given-names></name><name><surname>Jordan</surname><given-names>J</given-names></name></person-group><article-title>Influences of normobaric hypoxia training on metabolic risk markers in human subjects</article-title><source>Med Sci Sports Exerc</source><year>2008</year><volume>40</volume><fpage>1939</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e31817f1988</pub-id><pub-id pub-id-type="pmid">18845972</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schobersberger</surname><given-names>W</given-names></name><name><surname>Schmid</surname><given-names>P</given-names></name><name><surname>Lechleitner</surname><given-names>M</given-names></name><name><surname>von Duvillard</surname><given-names>SP</given-names></name><name><surname>H&#x000f6;rtnagl</surname><given-names>H</given-names></name><name><surname>Gunga</surname><given-names>HC</given-names></name><etal/></person-group><article-title>The effects of moderate altitude (1,700&#x000a0;m) on cardiovascular and metabolic variables in patients with metabolic syndrome</article-title><source>Eur J Appl Physiol</source><year>2000</year><volume>2003</volume><issue>88</issue><fpage>506</fpage><lpage>14</lpage></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greie</surname><given-names>S</given-names></name><name><surname>Humpeler</surname><given-names>E</given-names></name><name><surname>Gunga</surname><given-names>HC</given-names></name><name><surname>Koralewski</surname><given-names>E</given-names></name><name><surname>Klingler</surname><given-names>A</given-names></name><name><surname>Mittermayr</surname><given-names>M</given-names></name><etal/></person-group><article-title>Improvement of metabolic syndrome markers through altitude specific hiking vacations</article-title><source>J Endocrinol Invest</source><year>2006</year><volume>29</volume><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1007/BF03344138</pub-id><pub-id pub-id-type="pmid">16840826</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mair</surname><given-names>J</given-names></name><name><surname>Hammerer-Lercher</surname><given-names>A</given-names></name><name><surname>Mittermayr</surname><given-names>M</given-names></name><name><surname>Klingler</surname><given-names>A</given-names></name><name><surname>Humpeler</surname><given-names>E</given-names></name><name><surname>Pachinger</surname><given-names>O</given-names></name><etal/></person-group><article-title>3-week hiking holidays at moderate altitude do not impair cardiac function in individuals with metabolic syndrome</article-title><source>Int J Cardiol</source><year>2008</year><volume>123</volume><fpage>186</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2006.11.127</pub-id><pub-id pub-id-type="pmid">17316842</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Neumayr G, Fries D, Mittermayer M, Humpeler E, Klingler A, Schobersberger W, Spiesberger R, Pokan R, Schmid P: Effects of hiking at moderate and low altitude on cardiovascular parameters in male patients with metabolic syndrome: Austrian Moderate Altitude Study. Wilderness Environ Med. 2014, S1080-6032(14)00006-4.</mixed-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>T</given-names></name><name><surname>Ogasawara</surname><given-names>J</given-names></name><name><surname>Kizaki</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Ishibashi</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><etal/></person-group><article-title>The effects of exercise training on obesity-induced dysregulated expression of adipokines in white adipose tissue</article-title><source>Int J Endocrinol</source><year>2013</year><volume>2013</volume><fpage>801743</fpage><pub-id pub-id-type="doi">10.1155/2013/801743</pub-id><pub-id pub-id-type="pmid">24369466</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bonate</surname><given-names>PL</given-names></name></person-group><source>Analysis of pretest-posttest designs</source><year>2000</year><publisher-loc>Boca Raton</publisher-loc><publisher-name>Chapman &#x00026; Hall/CRC</publisher-name></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavie</surname><given-names>CJ</given-names></name><name><surname>Swift</surname><given-names>DL</given-names></name></person-group><article-title>Clinical strategies for managing dyslipidemias: emphasis on physical activity and exercise training</article-title><source>Am J Lifestyle Med</source><year>2014</year><volume>8</volume><fpage>235</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1177/1559827614528654</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durstine</surname><given-names>JL</given-names></name><name><surname>Grandjean</surname><given-names>PW</given-names></name><name><surname>Davis</surname><given-names>PG</given-names></name><name><surname>Ferguson</surname><given-names>MA</given-names></name><name><surname>Alderson</surname><given-names>NL</given-names></name><name><surname>DuBose</surname><given-names>KD</given-names></name></person-group><article-title>Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis</article-title><source>Sports Med</source><year>2001</year><volume>31</volume><fpage>1033</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.2165/00007256-200131150-00002</pub-id><pub-id pub-id-type="pmid">11735685</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>PA</given-names></name><name><surname>Barboriak</surname><given-names>J</given-names></name></person-group><article-title>The time course of alterations in plasma lipid and lipoprotein concentrations during eight weeks of endurance training</article-title><source>Atherosclerosis</source><year>1980</year><volume>37</volume><fpage>231</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/0021-9150(80)90008-8</pub-id><pub-id pub-id-type="pmid">7426097</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomiyasu</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Ikewaki</surname><given-names>K</given-names></name></person-group><article-title>Effects of exercise on plasma lipases and cholesterol ester transfer protein activities in normolipidemic male subjects</article-title><source>Nutr Metab Cardiovasc Dis</source><year>1996</year><volume>6</volume><fpage>13</fpage><lpage>20</lpage></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Despr&#x000e9;s</surname><given-names>JP</given-names></name><name><surname>Moorjani</surname><given-names>S</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><name><surname>Poehlman</surname><given-names>ET</given-names></name><name><surname>Lupien</surname><given-names>PJ</given-names></name><name><surname>Nadeau</surname><given-names>A</given-names></name><etal/></person-group><article-title>Heredity and changes in plasma lipids and lipoproteins after short-term exercise training in men</article-title><source>Arteriosclerosis</source><year>1988</year><volume>8</volume><fpage>402</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.8.4.402</pub-id><pub-id pub-id-type="pmid">3395276</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Crouse</surname><given-names>SF</given-names></name><name><surname>Goodpaster</surname><given-names>B</given-names></name><name><surname>Kelley</surname><given-names>D</given-names></name><name><surname>Moyna</surname><given-names>N</given-names></name><name><surname>Pescatello</surname><given-names>L</given-names></name></person-group><article-title>The acute versus the chronic response to exercise</article-title><source>Med Sci Sports Exerc</source><year>2001</year><volume>33</volume><issue>6 Suppl</issue><fpage>S438</fpage><lpage>S445</lpage><pub-id pub-id-type="doi">10.1097/00005768-200106001-00012</pub-id><pub-id pub-id-type="pmid">11427768</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dressendorfer</surname><given-names>RH</given-names></name><name><surname>Wade</surname><given-names>CE</given-names></name><name><surname>Hornick</surname><given-names>C</given-names></name><name><surname>Timmis</surname><given-names>GC</given-names></name></person-group><article-title>High-density lipoprotein-cholesterol in marathon runners during a 20-day road race</article-title><source>JAMA</source><year>1982</year><volume>247</volume><fpage>1715</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/jama.1982.03320370029024</pub-id><pub-id pub-id-type="pmid">6121063</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouse</surname><given-names>SF</given-names></name><name><surname>O'Brien</surname><given-names>BC</given-names></name><name><surname>Grandjean</surname><given-names>PW</given-names></name><name><surname>Lowe</surname><given-names>RC</given-names></name><name><surname>Rohack</surname><given-names>JJ</given-names></name><name><surname>Green</surname><given-names>JS</given-names></name></person-group><article-title>Effects of training and a single session of exercise on lipids and apolipoproteins in hypercholesterolemic men</article-title><source>J Appl Physiol (1985)</source><year>1997</year><volume>83</volume><fpage>2019</fpage><lpage>2028</lpage><pub-id pub-id-type="pmid">9390976</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullinane</surname><given-names>E</given-names></name><name><surname>Siconolfi</surname><given-names>S</given-names></name><name><surname>Saritelli</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name></person-group><article-title>Acute decrease in serum triglycerides with exercise: is there a threshold for an exercise effect?</article-title><source>Metabolism</source><year>1982</year><volume>31</volume><fpage>844</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/0026-0495(82)90085-3</pub-id><pub-id pub-id-type="pmid">7098853</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>MA</given-names></name><name><surname>Alderson</surname><given-names>NL</given-names></name><name><surname>Trost</surname><given-names>SG</given-names></name><name><surname>Essig</surname><given-names>DA</given-names></name><name><surname>Burke</surname><given-names>JR</given-names></name><name><surname>Durstine</surname><given-names>JL</given-names></name></person-group><article-title>Effects of four different single exercise sessions on lipids, lipoproteins, and lipoprotein lipase</article-title><source>J Appl Physiol (1985)</source><year>1998</year><volume>85</volume><fpage>1169</fpage><lpage>1174</lpage><pub-id pub-id-type="pmid">9729596</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>JM</given-names></name><name><surname>Herd</surname><given-names>SL</given-names></name><name><surname>Tsetsonis</surname><given-names>NV</given-names></name><name><surname>Hardman</surname><given-names>AE</given-names></name></person-group><article-title>Are the reductions in triacylglycerol and insulin levels after exercise related?</article-title><source>Clin Sci (Lond)</source><year>2002</year><volume>102</volume><fpage>223</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1042/CS20010204</pub-id><pub-id pub-id-type="pmid">11834142</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>FL</given-names></name><name><surname>Malkova</surname><given-names>D</given-names></name><name><surname>Caslake</surname><given-names>MJ</given-names></name><name><surname>Gill</surname><given-names>JM</given-names></name></person-group><article-title>Energy replacement attenuates the effects of prior moderate exercise on postprandial metabolism in overweight/obese men</article-title><source>Int J Obes (Lond)</source><year>2008</year><volume>32</volume><fpage>481</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0803754</pub-id><pub-id pub-id-type="pmid">17998903</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>M</given-names></name><name><surname>O'Gorman</surname><given-names>DJ</given-names></name><name><surname>McCaffrey</surname><given-names>N</given-names></name><name><surname>Hamilton</surname><given-names>MT</given-names></name><name><surname>Zderic</surname><given-names>TW</given-names></name><name><surname>Carson</surname><given-names>BP</given-names></name><name><surname>Moyna</surname><given-names>NM</given-names></name></person-group><article-title>Influence of acute exercise with and without carbohydrate replacement on postprandial lipid metabolism</article-title><source>J Appl Physiol (1985)</source><year>2009</year><volume>106</volume><fpage>943</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.91367.2008</pub-id><pub-id pub-id-type="pmid">19112157</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>TJ</given-names></name><name><surname>Palombella</surname><given-names>A</given-names></name><name><surname>McGuire</surname><given-names>KA</given-names></name><name><surname>Janiszewski</surname><given-names>PM</given-names></name><name><surname>Despr&#x000e9;s</surname><given-names>JP</given-names></name><name><surname>Ross</surname><given-names>R</given-names></name></person-group><article-title>Acute exercise increases adiponectin levels in abdominally obese men</article-title><source>J Nutr Metab</source><year>2012</year><volume>2012</volume><fpage>148729</fpage><pub-id pub-id-type="pmid">22701167</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackel-D&#x02019;Elia</surname><given-names>C</given-names></name><name><surname>Carnier</surname><given-names>J</given-names></name><name><surname>Bueno</surname><given-names>CR</given-names><suffix>Jr</suffix></name><name><surname>Campos</surname><given-names>RM</given-names></name><name><surname>Sanches</surname><given-names>PL</given-names></name><name><surname>Clemente</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Effects of different physical exercises on leptin concentration in obese adolescents</article-title><source>Int J Sports Med</source><year>2014</year><volume>35</volume><fpage>164</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">23868679</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanaley</surname><given-names>JA</given-names></name><name><surname>Fenicchia</surname><given-names>LM</given-names></name><name><surname>Miller</surname><given-names>CS</given-names></name><name><surname>Ploutz-Synder</surname><given-names>LL</given-names></name><name><surname>Weinstock</surname><given-names>RS</given-names></name><name><surname>Carhart</surname><given-names>R</given-names></name><etal/></person-group><article-title>Resting leptin responses to acute and chronic resistance training in type 2 diabetic men and women</article-title><source>Int J Obes Relat Metab Disord</source><year>2001</year><volume>25</volume><fpage>1474</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0801797</pub-id><pub-id pub-id-type="pmid">11673769</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>MD</given-names></name><name><surname>Patrizi</surname><given-names>RM</given-names></name><name><surname>Cheek</surname><given-names>DJ</given-names></name><name><surname>Wooten</surname><given-names>JS</given-names></name><name><surname>Barbee</surname><given-names>JJ</given-names></name><name><surname>Mitchell</surname><given-names>JB</given-names></name></person-group><article-title>Resistance training reduces subclinical inflammation in obese, postmenopausal women</article-title><source>Med Sci Sports Exerc</source><year>2012</year><volume>44</volume><fpage>2099</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3182644984</pub-id><pub-id pub-id-type="pmid">22874536</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>MS</given-names></name><name><surname>Houmard</surname><given-names>JA</given-names></name><name><surname>Considine</surname><given-names>RV</given-names></name><name><surname>Tyndall</surname><given-names>GL</given-names></name><name><surname>Midgette</surname><given-names>JB</given-names></name><name><surname>Gavigan</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Gender-dependent effects of exercise training on serum leptin levels in humans</article-title><source>Am J Physiol</source><year>1997</year><volume>272</volume><fpage>E562</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9142875</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Wee J, Climstein M: Hypoxic training: Clinical benefits on cardiometabolic risk factors. J Sci Med Sport. 2013. S1440-2440(13)00478-7.</mixed-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SM</given-names></name><name><surname>Lin</surname><given-names>HY</given-names></name><name><surname>Kuo</surname><given-names>CH</given-names></name></person-group><article-title>Altitude training improves glycemic control</article-title><source>Chin J Physiol</source><year>2013</year><volume>54</volume><fpage>193</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23806034</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>WC</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Ho</surname><given-names>HY</given-names></name><name><surname>Hou</surname><given-names>CW</given-names></name><name><surname>Liang</surname><given-names>MP</given-names></name><name><surname>Shen</surname><given-names>YW</given-names></name><etal/></person-group><article-title>Short-term altitude mountain living improves glycemic control</article-title><source>High Alt Med Biol</source><year>2003</year><volume>4</volume><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1089/152702903321489013</pub-id><pub-id pub-id-type="pmid">12713715</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname><given-names>R</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Peloso</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Common variants associated with plasma triglycerides and risk for coronary artery disease</article-title><source>Nat Genet</source><year>2013</year><volume>45</volume><fpage>1345</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1038/ng.2795</pub-id><pub-id pub-id-type="pmid">24097064</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tall</surname><given-names>AR</given-names></name></person-group><article-title>Exercise to reduce cardiovascular risk: how much is enough?</article-title><source>N Engl J Med</source><year>2002</year><volume>347</volume><fpage>1522</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1056/NEJMe020117</pub-id><pub-id pub-id-type="pmid">12421896</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>DC</given-names></name><name><surname>Barrett</surname><given-names>PH</given-names></name><name><surname>Watts</surname><given-names>GF</given-names></name></person-group><article-title>The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia</article-title><source>Best Pract Res Clin Endocrinol Metab</source><year>2014</year><volume>28</volume><fpage>369</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.beem.2013.10.001</pub-id><pub-id pub-id-type="pmid">24840265</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatouros</surname><given-names>IG</given-names></name><name><surname>Tournis</surname><given-names>S</given-names></name><name><surname>Leontsini</surname><given-names>D</given-names></name><name><surname>Jamurtas</surname><given-names>AZ</given-names></name><name><surname>Sxina</surname><given-names>M</given-names></name><name><surname>Thomakos</surname><given-names>P</given-names></name><etal/></person-group><article-title>Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><fpage>5970</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1210/jc.2005-0261</pub-id><pub-id pub-id-type="pmid">16091494</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatouros</surname><given-names>IG</given-names></name><name><surname>Chatzinikolaou</surname><given-names>A</given-names></name><name><surname>Tournis</surname><given-names>S</given-names></name><name><surname>Nikolaidis</surname><given-names>MG</given-names></name><name><surname>Jamurtas</surname><given-names>AZ</given-names></name><name><surname>Douroudos</surname><given-names>II</given-names></name><etal/></person-group><article-title>Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><fpage>2161</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.2337/dc08-1994</pub-id><pub-id pub-id-type="pmid">19729520</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>RR</given-names></name><name><surname>Chu</surname><given-names>H</given-names></name><name><surname>Castracane</surname><given-names>VD</given-names></name></person-group><article-title>Leptin and exercise</article-title><source>Exp Biol Med (Maywood)</source><year>2002</year><volume>227</volume><fpage>701</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12324651</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barwell</surname><given-names>ND</given-names></name><name><surname>Malkova</surname><given-names>D</given-names></name><name><surname>Moran</surname><given-names>CN</given-names></name><name><surname>Cleland</surname><given-names>SJ</given-names></name><name><surname>Packard</surname><given-names>CJ</given-names></name><name><surname>Zammit</surname><given-names>VA</given-names></name><etal/></person-group><article-title>Exercise training has greater effects on insulin sensitivity in daughters of patients with type 2 diabetes than in women with no family history of diabetes</article-title><source>Diabetologia</source><year>2008</year><volume>51</volume><fpage>1912</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s00125-008-1097-6</pub-id><pub-id pub-id-type="pmid">18663427</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Wannamethee</surname><given-names>G</given-names></name><name><surname>Sarwar</surname><given-names>N</given-names></name><name><surname>Chernova</surname><given-names>J</given-names></name><name><surname>Lawlor</surname><given-names>DA</given-names></name><name><surname>Kelly</surname><given-names>A</given-names></name><etal/></person-group><article-title>Leptin and coronary heart disease: prospective study and systematic review</article-title><source>J Am Coll Cardiol</source><year>2009</year><volume>53</volume><fpage>167</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2008.09.035</pub-id><pub-id pub-id-type="pmid">19130985</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabrera de Le&#x000f3;n</surname><given-names>A</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>DA</given-names></name><name><surname>M&#x000e9;ndez</surname><given-names>LI</given-names></name><name><surname>Aguirre-Jaime</surname><given-names>A</given-names></name><name><surname>del Cristo Rodr&#x000ed;guez P&#x000e9;rez</surname><given-names>M</given-names></name><name><surname>Coello</surname><given-names>SD</given-names></name><name><surname>Trujillo</surname><given-names>IC</given-names></name></person-group><article-title>Leptin and altitude in the cardiovascular diseases</article-title><source>Obes Res</source><year>2004</year><volume>12</volume><fpage>1492</fpage><lpage>1498</lpage><pub-id pub-id-type="doi">10.1038/oby.2004.186</pub-id><pub-id pub-id-type="pmid">15483214</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roels</surname><given-names>B</given-names></name><name><surname>Thomas</surname><given-names>C</given-names></name><name><surname>Bentley</surname><given-names>DJ</given-names></name><name><surname>Mercier</surname><given-names>J</given-names></name><name><surname>Hayot</surname><given-names>M</given-names></name><name><surname>Millet</surname><given-names>G</given-names></name></person-group><article-title>Effects of intermittent hypoxic training on amino and fatty acid oxidative combustion in human permeabilized muscle fibers</article-title><source>J Appl Physiol (1985)</source><year>2007</year><volume>102</volume><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01319.2005</pub-id><pub-id pub-id-type="pmid">16990498</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kon</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Homma</surname><given-names>T</given-names></name><name><surname>Akimoto</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Kawahara</surname><given-names>T</given-names></name></person-group><article-title>Effects of acute hypoxia on metabolic and hormonal responses to resistance exercise</article-title><source>Med Sci Sports Exerc</source><year>2010</year><volume>42</volume><fpage>1279</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181ce61a5</pub-id><pub-id pub-id-type="pmid">20019623</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiesner</surname><given-names>S</given-names></name><name><surname>Haufe</surname><given-names>S</given-names></name><name><surname>Engeli</surname><given-names>S</given-names></name><name><surname>Mutschler</surname><given-names>H</given-names></name><name><surname>Haas</surname><given-names>U</given-names></name><name><surname>Luft</surname><given-names>FC</given-names></name><etal/></person-group><article-title>Influences of normobaric hypoxia training on physical fitness and metabolic risk markers in overweight to obese subjects</article-title><source>Obesity (Silver Spring)</source><year>2010</year><volume>18</volume><fpage>116</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/oby.2009.193</pub-id><pub-id pub-id-type="pmid">19543214</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Miettinen</surname><given-names>H</given-names></name><name><surname>Mykk&#x000e4;nen</surname><given-names>L</given-names></name><name><surname>Karhap&#x000e4;&#x000e4;</surname><given-names>P</given-names></name><name><surname>Rainwater</surname><given-names>DL</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name></person-group><article-title>Leptin concentrations and insulin sensitivity in normoglycemic men</article-title><source>Int J Obes Relat Metab Disord</source><year>1997</year><volume>21</volume><fpage>393</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0800419</pub-id><pub-id pub-id-type="pmid">9152742</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Hanefeld</surname><given-names>M</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Fusch</surname><given-names>C</given-names></name><name><surname>Schwanebeck</surname><given-names>U</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>C</given-names></name><etal/></person-group><article-title>Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass</article-title><source>Acta Diabetol</source><year>2002</year><volume>39</volume><fpage>105</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s005920200027</pub-id><pub-id pub-id-type="pmid">12357293</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crunkhorn</surname><given-names>S</given-names></name></person-group><article-title>Metabolic disease: exercise hormone fights metabolic disease</article-title><source>Nat Rev Drug Discov</source><year>2012</year><volume>11</volume><fpage>189</fpage><pub-id pub-id-type="doi">10.1038/nrd3686</pub-id><pub-id pub-id-type="pmid">22338642</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>ED</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><article-title>What we talk about when we talk about fat</article-title><source>Cell</source><year>2014</year><volume>156</volume><fpage>20</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.12.012</pub-id><pub-id pub-id-type="pmid">24439368</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bostr&#x000f6;m</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Jedrychowski</surname><given-names>MP</given-names></name><name><surname>Korde</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Lo</surname><given-names>JC</given-names></name><etal/></person-group><article-title>A PGC1-&#x003b1;-dependent myokine that drives brown-fat-like development of white fat and thermogenesis</article-title><source>Nature</source><year>2012</year><volume>481</volume><fpage>463</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nature10777</pub-id><pub-id pub-id-type="pmid">22237023</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittle</surname><given-names>AJ</given-names></name><name><surname>Carobbio</surname><given-names>S</given-names></name><name><surname>Martins</surname><given-names>L</given-names></name><name><surname>Slawik</surname><given-names>M</given-names></name><name><surname>Hondares</surname><given-names>E</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions</article-title><source>Cell</source><year>2012</year><volume>149</volume><fpage>871</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.02.066</pub-id><pub-id pub-id-type="pmid">22579288</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crujeiras</surname><given-names>AB</given-names></name><name><surname>Pardo</surname><given-names>M</given-names></name><name><surname>Arturo</surname><given-names>RR</given-names></name><name><surname>Navas-Carretero</surname><given-names>S</given-names></name><name><surname>Zulet</surname><given-names>MA</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women</article-title><source>Am J Hum Biol</source><year>2014</year><volume>26</volume><fpage>198</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1002/ajhb.22493</pub-id><pub-id pub-id-type="pmid">24375850</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="other">Crujeiras AB, Pardo M, Casanueva FF. Irisin: &#x02018;fat&#x02019; or artefact. Clin Endocrinol (Oxf). 2014. doi: 10.1111/cen.12627. [Epub ahead of print]</mixed-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss-Blasche</surname><given-names>G</given-names></name><name><surname>Riedmann</surname><given-names>B</given-names></name><name><surname>Schobersberger</surname><given-names>W</given-names></name><name><surname>Ekmekcioglu</surname><given-names>C</given-names></name><name><surname>Riedmann</surname><given-names>G</given-names></name><name><surname>Waanders</surname><given-names>R</given-names></name><etal/></person-group><article-title>Vacation at moderate and low altitude improves perceived health in individuals with metabolic syndrome</article-title><source>J Travel Med</source><year>2004</year><volume>11</volume><fpage>300</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.2310/7060.2004.19106</pub-id><pub-id pub-id-type="pmid">15544714</pub-id></element-citation></ref></ref-list></back></article>